Arrhythmogenic right ventricular cardiomyopathy

Journal of Arrhythmia
Yongkeun Cho

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive cardiomyopathy characterized by fibrofatty infiltration of the myocardium, ventricular arrhythmias, sudden death, and heart failure. ARVC may be an important cause of syncope, sudden death, ventricular arrhythmias, and/or wall motion abnormalities, especially in the young. As the first symptom is sudden death or cardiac arrest in many cases, an early diagnosis and risk stratification are important. Recent advances in diagnostic modalities will be helpful in the early diagnosis and proper management of patients at risk. Restriction of strenuous exercise and implantation of implantable cardioverter-defibrillators are important in addition to medical treatment and catheter ablation of ventricular tachycardia. Recently introduced genetic screening may help to identify asymptomatic carriers with a risk of a disease progression and sudden death.

References

Feb 1, 1982·Circulation·F I MarcusY Grosgogeat
Oct 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Yongkeun ChoWee-Hyun Park
Dec 10, 2003·Journal of the American College of Cardiology·Domenico CorradoGaetano Thiene
Nov 25, 2004·International Journal of Cardiology·Stefan PetersWerner Meyners
Mar 16, 2005·Journal of the American College of Cardiology·Danita M YoergerUNKNOWN Multidisciplinary Study of Right Ventricular Dysplasia Investigators
May 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Hyungseop KimHun Sik Park
Oct 5, 2006·JAMA : the Journal of the American Medical Association·Domenico CorradoGaetano Thiene
Oct 13, 2006·Herz·Domenico CorradoGaetano Thiene
Nov 6, 2007·Journal of the American College of Cardiology·Srijita Sen-ChowdhryWilliam J McKenna
Dec 20, 2008·Journal of the American College of Cardiology·Srijita Sen-ChowdhryWilliam J McKenna
Mar 13, 2009·The New England Journal of Medicine·Angeliki AsimakiJeffrey E Saffitz
Apr 14, 2009·Lancet·Cristina BassoGaetano Thiene
Aug 8, 2009·Journal of the American College of Cardiology·Gregory M MarcusUNKNOWN Multidisciplinary Study of Right Ventricular Dysplasia Investigators
Feb 16, 2010·Journal of the American College of Cardiology·Tianhong XuUNKNOWN Multidisciplinary Study of Right Ventricular Dysplasia Investigators
Apr 20, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Veronique FressartPhilippe Charron
Nov 19, 2010·Medicine and Science in Sports and Exercise·André La GercheDavid L Prior
Feb 1, 2011·European Heart Journal·Domenico CorradoGaetano Thiene
Jun 4, 2011·Journal of the American College of Cardiology·Jamie D KapplingerMichael J Ackerman
Jul 5, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Barbara BauceAndrea Nava
Aug 4, 2011·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Michael J AckermanUNKNOWN European Heart Rhythm Association (EHRA)
Jan 14, 2012·Journal of the American College of Cardiology·Ryan J TedfordStuart D Russell
Apr 12, 2012·Circulation. Arrhythmia and Electrophysiology·Binu PhilipsHarikrishna Tandri
Feb 9, 2013·Circulation. Arrhythmia and Electrophysiology·Federico MiglioreDomenico Corrado
Sep 3, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Christian F CammHugh Calkins
Oct 16, 2013·Circulation. Cardiovascular Genetics·Jingru BaoLei Song

❮ Previous
Next ❯

Methods Mentioned

BETA
Transmission electron microscopy
biopsy
biopsies
imaging technique

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.